Organoids are not the cure-all people think they are

A long thread from Dan O'Callaghan breaks down the hype around organoids — lab-grown mini-organs — and why they haven't delivered the medical revolution everyone expected. The short version: growing a tiny liver or brain slice in a dish is impressive, but it doesn't mean you've got the real thing. The wiring is wrong, the scale is off, and the blood supply is missing. What you get is a useful approximation for some experiments, not a substitute for a human organ.

The broader point is about a pattern in biotech where a clever technique gets inflated into a product. Organoids are genuinely useful for studying disease mechanisms and drug screening — they're a step up from cell lines. But they're not a shortcut to cures, and they're certainly not a path to transplant organs any time soon. The hype cycle moves faster than the biology.

Why this matters for us: the same kind of overpromise shows up in AI and health apps — big claims, thin evidence, and a lot of venture money chasing the next headline. We'd rather the money went to things that actually work for people in the neighborhood.